Approach to Dyslipidemia, Lipodystrophy,
β
J. Gregory Troll
π
Article
π
2010
π
Current Science Inc.
π
English
β 130 KB
There is a significant prevalence (20%β80% depending on the population and the study) of lipid disorders and other cardiovascular risk factors in people living with HIV infection. This review focuses on HIV and HIV treatmentβassociated metabolic and cardiovascular concerns, including dyslipidemias,